Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge

doi:10.1016/j.vaccine.2019.10.049

Title: Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge

Full Record
Other Related Research

Authors:: Russo, Andrew T.; Berhanu, Aklile; Bigger, Catherine B.; Prigge, Jon; Silvera, Peter M.; Grosenbach, Douglas W.; Hruby, Dennis

Publication Date:: 2020-01-01

Sponsoring Org.:: USDOE

OSTI Identifier:: 1581454

Grant/Contract Number:: 5R44AI075747

Resource Type:: Published Article

Journal Name:: Vaccine

Additional Journal Information:: Journal Name: Vaccine Journal Volume: 38 Journal Issue: 3; Journal ID: ISSN 0264-410X

Publisher:: Elsevier

Country of Publication:: United Kingdom

Language:: English

Citation Formats


                    Russo, Andrew T., Berhanu, Aklile, Bigger, Catherine B., Prigge, Jon, Silvera, Peter M., Grosenbach, Douglas W., and Hruby, Dennis. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.  United Kingdom: N. p., 2020. 
        Web.  doi:10.1016/j.vaccine.2019.10.049.

Copy to clipboard


                    Russo, Andrew T., Berhanu, Aklile, Bigger, Catherine B., Prigge, Jon, Silvera, Peter M., Grosenbach, Douglas W., & Hruby, Dennis. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.  United Kingdom.  doi:10.1016/j.vaccine.2019.10.049.

Copy to clipboard


                    Russo, Andrew T., Berhanu, Aklile, Bigger, Catherine B., Prigge, Jon, Silvera, Peter M., Grosenbach, Douglas W., and Hruby, Dennis. Wed .  
        "Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge".  United Kingdom.  doi:10.1016/j.vaccine.2019.10.049.

Copy to clipboard


                    
@article{osti_1581454,

  title        = {Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge},

  author       = {Russo, Andrew T. and Berhanu, Aklile and Bigger, Catherine B. and Prigge, Jon and Silvera, Peter M. and Grosenbach, Douglas W. and Hruby, Dennis},

  abstractNote = {},

  doi          = {10.1016/j.vaccine.2019.10.049},

  journal      = {Vaccine},

  number       = 3,

  volume       = 38,

  place        = {United Kingdom},

  year         = {2020},

  month        = {1}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Publisher's Version of Record
DOI: 10.1016/j.vaccine.2019.10.049

Other availability

Search WorldCat to find libraries that may hold this journal

Save / Share:

Export Metadata

Save to My Library

Similar records in OSTI.GOV collections:

Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge

Journal Article Konduru, Krishnamurthy ; Shurtleff, Amy C. ; Bradfute, Steven B. ; ... - PLoS ONE

Ebola virus (EBOV), a member of the Filoviridae that can cause severe hemorrhagic fever in humans and nonhuman primates, poses a significant threat to the public health. Currently, there are no licensed vaccines or therapeutics to prevent and treat EBOV infection. Several vaccines based on the EBOV glycoprotein (GP) are under development, including vectored, virus-like particles, and protein-based subunit vaccines. We previously demonstrated that a subunit vaccine containing the extracellular domain of the Ebola ebolavirus (EBOV) GP fused to the Fc fragment of human IgG1 (EBOVgp-Fc) protected mice against EBOV lethal challenge. Here, we show that the EBOVgp-Fc vaccine formulatedmore »« less
Cited by 7
DOI: 10.1371/journal.pone.0162446

Full Text Available
Pre- and post-exposure safety and efficacy of attenuated rabies virus vaccines are enhanced by their expression of IFNγ

Journal Article Barkhouse, Darryll A. ; Center for Neurovirology 1020 Locust St., Jefferson Alumni Hall, Room 454, Philadelphia, PA 19107 ; Faber, Milosz ; ... - Virology

Consistent with evidence of a strong correlation between interferon gamma (IFNγ) production and rabies virus (RABV) clearance from the CNS, we recently demonstrated that engineering a pathogenic RABV to express IFNγ highly attenuates the virus. Reasoning that IFNγ expression by RABV vaccines would enhance their safety and efficacy, we reverse-engineered two proven vaccine vectors, GAS and GASGAS, to express murine IFNγ. Mortality and morbidity were monitored during suckling mice infection, immunize/challenge experiments and mixed intracranial infections. We demonstrate that GASγ and GASγGAS are significantly attenuated in suckling mice compared to the GASGAS vaccine. GASγ better protects mice from lethal DRV4more »« less
DOI: 10.1016/J.VIROL.2014.10.025
Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge

Journal Article Nachbagauer, Raffael ; Shore, David ; Yang, Hua ; ... - Journal of Virology

ABSTRACT Broadly cross-reactive antibodies (Abs) that recognize conserved epitopes within the influenza virus hemagglutinin (HA) stalk domain are of particular interest for their potential use as therapeutic and prophylactic agents against multiple influenza virus subtypes, including zoonotic virus strains. Here, we characterized four human HA stalk-reactive monoclonal antibodies (MAbs) for their binding breadth and affinity,in vitroneutralization capacity, andin vivoprotective potential against an highly pathogenic avian influenza virus. The monoclonal antibodies were isolated from individuals shortly following infection with (70-1F02 and 1009-3B05) or vaccination against (05-2G02 and 09-3A01) A(H1N1)pdm09. Three of the MAbs bound HAs from multiple strains of group 1more »« less
DOI: 10.1128/JVI.00949-18
Protection of non-human primates against rabies with an adenovirus recombinant vaccine

Journal Article Xiang, Z.Q. ; Greenberg, L. ; Ertl, H.C., E-mail: ertl@wistar.upenn.edu ; ... - Virology

Rabies remains a major neglected global zoonosis. New vaccine strategies are needed for human rabies prophylaxis. A single intramuscular immunization with a moderate dose of an experimental chimpanzee adenovirus (Ad) vector serotype SAd-V24, also termed AdC68, expressing the rabies virus glycoprotein, resulted in sustained titers of rabies virus neutralizing antibodies and protection against a lethal rabies virus challenge infection in a non-human primate model. Taken together, these data demonstrate the safety, immunogenicity, and efficacy of the recombinant Ad-rabies vector for further consideration in human clinical trials. - Highlights: • Pre-exposure vaccination with vaccine based on a chimpanzee derived adenovirus protectsmore »« less
DOI: 10.1016/J.VIROL.2013.12.029
Protection of Rhesus monkeys against Soman and prevention of performance decrement by pretreatment with acetylcholinesterase. (Reannouncement with new availability information)

Technical Report Maxwell, D.M. ; Castro, C.A. ; De La Hoz, D.M. ; ...

The ability of acetylcholinesterase from fetal bovine serum (FBS AChE) to protect against soman, a highly toxic organophosphorus (OP) compound, was tested in rhesus monkeys. Intravenous administration of FBS AChE produced a minimal behavioral effect on the serial probe recognition task, a sensitive test of cognitive function and short-term memory. Pharmacokinetic studies of injected FBS AChE indicated a plasma half-life of 40 hr for FBS AChE in monkeys. Both in vitro and in vivo titration of FBS AChE with soman produced a 1:1 stoichiometry between organophosphate-inhibited FBS AChE and the cumulative dose of the toxic stereoisomers of soman. Administration ofmore »« less

Similar Records